MX9701528A - Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer. - Google Patents

Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer.

Info

Publication number
MX9701528A
MX9701528A MX9701528A MX9701528A MX9701528A MX 9701528 A MX9701528 A MX 9701528A MX 9701528 A MX9701528 A MX 9701528A MX 9701528 A MX9701528 A MX 9701528A MX 9701528 A MX9701528 A MX 9701528A
Authority
MX
Mexico
Prior art keywords
triphenylbut
alzheimers disease
ene derivatives
treating alzheimers
methyl
Prior art date
Application number
MX9701528A
Other languages
English (en)
Other versions
MXPA97001528A (es
Inventor
David B Maclean
David D Thompson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9701528A publication Critical patent/MX9701528A/es
Publication of MXPA97001528A publication Critical patent/MXPA97001528A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion proporciona el nuevo uso de un compuesto de formula I en la que R1 y R2 pueden ser iguales o diferentes, con la condicion de que cuando R1 y R2 so iguales, cada uno es un grupo metilo o etilo y cuando R1 y R2 son diferentes, uno de ellos es un grupo metilo o etilo y el otro es hidrogeno o grupo bencilo, o una sal farmacéuticamente aceptable del mismo en la preparacion de composiciones para inhibir la enfermedad de Alzheimer, que comprenden administrar a una persona que necesite dicho tratamiento.
MXPA/A/1997/001528A 1996-02-28 1997-02-27 Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer MXPA97001528A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2520196P 1996-02-28 1996-02-28
US025201 1996-02-28

Publications (2)

Publication Number Publication Date
MX9701528A true MX9701528A (es) 1998-06-28
MXPA97001528A MXPA97001528A (es) 1998-10-30

Family

ID=

Also Published As

Publication number Publication date
ZA971716B (en) 1998-08-27
CA2198561A1 (en) 1997-08-28
EP0792638A1 (en) 1997-09-03
IL120269A0 (en) 1997-06-10
AU1496597A (en) 1997-09-04
KR970061248A (ko) 1997-09-12
CN1165650A (zh) 1997-11-26
JPH09315961A (ja) 1997-12-09
US5719191A (en) 1998-02-17

Similar Documents

Publication Publication Date Title
GB0005251D0 (en) Therapeutic compounds
MY123354A (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
MY119403A (en) Novel compounds with analgesic effect.
NO179250C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktiv (+)--(2,3-dimetoksyfenyl)-1-[2-(4-fluorfenyl)etylÅ-4-piperidinmetanol
UA41355C2 (uk) Засіб для лікування нейро-сніду
PL309594A1 (en) Apllication of rilusole in treating parkinson disease and parkinsonian syndromes
MY119375A (en) Treatment of tinnitus using neuroprotective agents
IL130083A0 (en) 3-Pyridyl enantiomers and their use as analgesics
RU94044453A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования себореи и угрей
DE69637050D1 (de) Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer
RU94044454A (ru) Ингибитор аутоимунных заболеваний
RU94044489A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования миелопероксидазной активности
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
GB9108629D0 (en) Heterocyclic pharmaceutical compounds,preparation and use
CA2289017A1 (en) The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
BG105342A (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
IL118833A (en) Sertraline for use as a medicament in the treatment of post-myocardial infarction patients
MX9701528A (es) Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer.
ES2157961T3 (es) Inhibicion del hirsutismo y la alopecia en mujeres.
MX9701333A (es) Metodos para inhibir el daño neuronal.
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
NZ268039A (en) Use of efaroxan in treating parkinson's disease
MX9701606A (es) Terapia de combinacion para evitar la perdida osea-progesterona y agonistas de estrogeno.
MX9701529A (es) Uso de (e)-1-[4'-(2-alquilaminoetoxi)fenil]-1-(3'-hidroxifenil)-2-f enilbut-1-enos para inhibir trastornos patologicos.
NZ268914A (en) Use of efaroxan and derivatives to prepare medicaments for treating neurodegenerative diseases especially alzheimer's disease

Legal Events

Date Code Title Description
FA Abandonment or withdrawal